Three-year Outcomes of Intravitreal Aflibercept versus Laser Therapy for Retinopathy of Prematurity. Stahl A, Nakanishi H, Lepore D, Wu WC, et al. Neonatology 2026 Jan 8:1-19. doi: 10.1159/000549717.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stahl A, Nakanishi H, Lepore D, Wu WC, et al. Three-year Outcomes of Intravitreal Aflibercept versus Laser Therapy for Retinopathy of Prematurity. Neonatology 2026 Jan 8:1-19. doi: 10.1159/000549717.
PMID: 41505377